Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03512223 · ClinicalTrials.gov registry record · Early Phase 1
Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery
A Early Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 108
- Enrollment target
NCT03512223 is a Early Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 108 participants.
The verdict
NCT03512223, a Early Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 108 participants
- Enrollment target
Study Summary
This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone in patients undergoing hand surgery.
Interventions
- DRUG Dexamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2018-10-23 |
| Est. Completion | 2024-10-20 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03512223
The ClinicalTrials.gov registry entry for NCT03512223 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.
NCT03512223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03512223 about?
NCT03512223 is a clinical study titled "Intravenous and Perineural Dexamethasone for Brachial Plexus Block in Hand Surgery". This study aims to evaluate the if the administration of dexamethasone both around the nerve and in the vein (perineural and intravenous (IV)) will prolong the duration of pain relief from ropivacaine when compared with ropivacaine local block alone or when administered along with IV dexamethasone i...
What is the current status of trial NCT03512223?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 108 participants. The study started on 2018-10-23. Estimated completion is 2024-10-20.
What interventions are being tested in trial NCT03512223?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03512223?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.